vimarsana.com

Page 8 - மருத்துவமனை டெல் மார் மருத்துவ ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study finds beefy good cholesterol may increase heart attack risk

Health experts have long advised their patients to make dietary changes that reduce their LDL ‘bad’ cholesterol while increasing their HDL ‘good’ cholesterol. However, studies have shown a bit of paradox in the sense that raising HDL cholesterol doesn’t necessarily reduce heart disease risk and the reason, according to the latest research, may be problems associated with big versus small cholesterol particles. Put simply, ‘bad’ LDL cholesterol is the kind that causes a build-up in the arteries, putting someone at risk of heart disease and related issues. ‘Good’ HDL cholesterol, meanwhile, shuttles cholesterol from the arteries to the liver for elimination.

The unveiling of a novel mechanism of resistance to immunotherapy targeting HER2

 E-Mail IMAGE: Joaquín Arribas, co-Program Director of Preclinical and Translational Research at VHIO, ICREA Professor, CIBERONC Investigator, Director of the Hospital del Mar Medical Research Institute (IMIM). view more  Credit: VHIO Redirection of lymphocytes, via T-cell bispecific antibodies (TCBs) and chimeric antigen receptors (CARs), is already approved to treat some hematologic malignancies. In solid tumors these immune-based strategies continue to fail. Research led by Joaquín Arribas, co-Program Director of Preclinical and Translational Research at VHIO, has now shown how HER2 breast cancer cells adopt a strategy to resist clearance by redirected lymphocytes. Findings evidence that the disruption of interferon-gamma signaling confers resistance to these immunotherapies and promotes disease progression.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.